MedTrace Logo

Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease

NCT02410811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2020-11-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to use cardiac magnetic resonance imaging (CMR) and echocardiographic tissue Doppler imaging to demonstrate a unique restrictive cardiomyopathy of sickle cell disease. The investigators will characterize its frequency and how it might change (e.g., presence/absence and severity) over a 2-year period.

Conditions

Interventions

OTHER

Cardiac magnetic resonance imaging (CMR)

CMR is obtained on all participants in all arms/groups

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Charles T Quinn, M.D. · Children's Hospital Medical Center, Cincinnati

  • Michael D Taylor, MD · Children's Hospital Medical Center, Cincinnati

  • Robert J Fleck, M.D. · Children's Hospital Medical Center, Cincinnati

  • Omar Y Niss, M.D. · Children's Hospital Medical Center, Cincinnati

Eligibility

Min Age
6 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-01-29
Completion
2019-05-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02410811 on ClinicalTrials.gov